Clinical Trial Update: A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating carboplatin/etoposide with or without atezolizumab in untreated extensive-stage small cell lung cancer has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Small Cell Lung Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2019-06-13